Not applicableStudy completedNCT01702610
What this trial is testing
Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Who this might be right for
Glioblastoma Mutliforme
McGill University Health Centre/Research Institute of the McGill University Health Centre 50